{
    "nctId": "NCT05054010",
    "briefTitle": "Identification of Breast Cancer Specific Markers in Patients Compared to Healthy Participants",
    "officialTitle": "Identification and Characterization of Commercial RUO Antibodies for the Detection of Specific Breast Cancer Tumoral Markers Expressed in Potential Circulating Tumoral Cells (CTCs)",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Neoplasms",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 60,
    "primaryOutcomeMeasure": "Number of commercial Antibodies capable of Identify specific Breast Cancer Biomarkers",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Participant is willing and able to give and sign a written informed consent for participation in the study.\n* Female aged 18 years or above.\n* Diagnosed with early breast cancer (stage I and II) or metastatic breast cancer.\n* Healthy participants who visit the site for reason other than cancer diagnosis (including breast cancer).\n\nExclusion Criteria:\n\n* History of other malignancies other than breast cancer (for healthy participants includes also breast cancer).\n* Undergone surgery or treatment for breast cancer before enrollment (only for early breast cancer).\n* Presence of known severe coagulation or haematological disorder\n* Known Pregnancy\n* Absence of written signed informed consent for participation in the study",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}